Bio-Path Holdings Inc. Common Stock. Replay the stock market charts of BPTH day by day back to 2003. Open long and short positions without spending any money. Bio-Path Holdings Inc is a clinical and preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
